Profile: JW Holdings Corp (096760.KS)
096760.KS on Korea Stock Exchange
Price Change (% chg)
JW HOLDINGS CORPORATION is a Korea-based holding company mainly engaged in the subsidiary management and pharmaceutical distribution businesses. The Company's products are imipenem, itraconazole, nutrients fluids, general fluids and others. Its subsidiaries include JW PHARMACEUTICAL CORPORATION, engaged in the manufacture of pharmaceuticals, such as diabetic agents, urology agents, nephrology agents and others; JW SHINYAK CORPORATION, engaged in the manufacture of pharmaceuticals, such as antibiotics, skin drugs, obesity drugs, allergy drugs and others, and JW Medical Corporation, engaged in the manufacture of medical equipment, such as magnetic resonance imaging (MRI) equipment, computed tomography (CT) equipment and others, among others. On June 14, 2013, the Company sold additional shares of JW Life Science. After the transaction, it held a 39.34% stake in JW Life Science.
JW Holdings Corp
1424-2, Seocho-Dong, Seocho-Gu